Abstract
Although hypocholesterolemia is a reported finding in sickle cell disease (SCD), low-density lipoprotein (LDL)/high-density lipoprotein (HDL) subfractions and HDL-associated enzymes have not been determined in SCD patients. Blood was collected from 38 hemoglobin (Hb)A volunteers and 45 homozygous HbSS patients who had not received blood transfusions in the last 3 months. Serum lipids were measured by automated analyzer while LDL and HDL subfraction analysis was done by continuous disc polyacrylamide gel electrophoresis. Serum levels of cholesteryl ester transfer protein (CETP), lecithin-cholesterol acyltransferase (LCAT), apolipoprotein B (apoB) and apolipoprotein A-1 (apoA-I) were determined by enzyme-linked immunosorbent assay (ELISA). Total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) levels were significantly decreased, while TG levels were significantly increased in SCD patients compared to controls. A significant decrease in intermediate-density lipoprotein (IDL)-C, IDL-B, IDL-A and LDL-1 fractions were seen in SCD patients, while no significant difference was observed in small dense LDL particles. A significant decrease was seen in HDL-large, HDL-intermediate and HDL-small fractions in SCD patients versus controls. Levels of LCAT and ApoA-1 protein measured in SCD patients were significantly lower while no significant difference was observed in CETP and ApoB protein levels compared to controls. The reduction observed in LDL- and HDL-C in SCD patients was reflected as significantly decreased IDL, LDL-1 and HDL-subfractions. Decreased HDL subfractions may possibly lead to the reduced ApoA-1 and LCAT protein levels observed in SCD patients.
Similar content being viewed by others
Abbreviations
- apoA-I:
-
Apolipoprotein A-1
- apoB:
-
Apolipoprotein B
- BMI:
-
Body mass index
- CETP:
-
Cholesteryl ester transfer protein
- CVD:
-
Cardiovascular disease
- ELISA:
-
Enzyme-linked immunosorbent assay
- Hb:
-
Hemoglobin
- HbF:
-
Fetal Hb
- HDL:
-
High-density lipoprotein
- HDL-C:
-
High-density lipoprotein cholesterol
- HRP:
-
Horseradish peroxidase
- IDL-C:
-
Intermediate-density lipoprotein cholesterol
- LCAT:
-
Lecithin-cholesterol acyltransferase
- LDL:
-
Low-density lipoprotein
- LDL-C:
-
Low-density lipoprotein cholesterol
- VLDL:
-
Very-low-density lipoprotein cholesterol
- mAb:
-
Monoclonal antibody
- MID:
-
Middle
- RBC:
-
Red blood cell
- SCD:
-
Sickle cell disease
- TC:
-
Total cholesterol
- TMB:
-
Tetramethylbenzidine
References
Aslan M, Freeman BA (2004) Oxidant-mediated impairment of nitric oxide signaling in sickle cell disease—mechanisms and consequences. Cell Mol Biol (Noisy-le-grand) 50(1):95–105
Aslan M, Freeman BA (2007) Redox-dependent impairment of vascular function in sickle cell disease. Free Radic Biol Med 43(11):1469–1483
Aslan M, Ryan TM, Adler B, Townes TM, Parks DA, Thompson JA, Tousson A, Gladwin MT, Patel RP, Tarpey MM, Batinic-Haberle I, White CR, Freeman BA (2001) Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proc Natl Acad Sci USA 98(26):15215–15220
Kupesiz A, Celmeli G, Dogan S, Antmen B, Aslan M (2012) The effect of hemolysis on plasma oxidation and nitration in patients with sickle cell disease. Free Radic Res 46(7):883–890
Aslan M, Canatan D (2008) Modulation of redox pathways in neutrophils from sickle cell disease patients. Exp Hematol 36(11):1535–1544
Reiter CD, Wang X, Tanus-Santos JE, Hogg N, Cannon RO 3rd, Schechter AN, Gladwin MT (2002) Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 8(12):1383–1389
Morris CR, Kato GJ, Poljakovic M, Wang X, Blackwelder WC, Sachdev V, Hazen SL, Vichinsky EP, Morris SM Jr, Gladwin MT (2005) Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA 294(1):81–90
Hoppe C, Kuypers F, Larkin S, Hagar W, Vichinsky E, Styles L (2011) A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction. Br J Haematol 153(5):655–663
Kato GJ, Gladwin MT (2008) Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy. JAMA 300(22):2638–2646
Yuditskaya S, Tumblin A, Hoehn GT, Wang G, Drake SK, Xu X, Ying S, Chi AH, Remaley AT, Shen RF, Munson PJ, Suffredini AF, Kato GJ (2009) Proteomic identification of altered apolipoprotein patterns in pulmonary hypertension and vasculopathy of sickle cell disease. Blood 113(5):1122–1128
VanderJagt DJ, Shores J, Okorodudu A, Okolo SN, Glew RH (2002) Hypocholesterolemia in Nigerian children with sickle cell disease. J Trop Pediatr 48(3):156–161
Chapman MJ, Guérin M, Bruckert E (1998) Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches. Eur Heart J 19(Suppl A):A24–A30
Asztalos BF, Cupples LA, Demissie S, Horvath KV, Cox CE, Batista MC, Schaefer EJ (2004) High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 24(11):2181–2187
Soran H, Hama S, Yadav R, Durrington PN (2012) HDL functionality. Curr Opin Lipidol 23(4):353–366
Sasaki J, Waterman MR, Buchanan GR, Cottam GL (1983) Plasma and erythrocyte lipids in sickle cell anaemia. Clin Lab Haematol 5(1):35–44
Aslan I, Kucuksayan E, Aslan M (2013) Effect of insulin analog initiation therapy on LDL/HDL subfraction profile and HDL associated enzymes in type 2 diabetic patients. Lipids Health Dis 12:54
Aslan M, Ozcan F, Kucuksayan E (2013) Increased small dense LDL and decreased paraoxonase enzyme activity reveals formation of an atherogenic risk in streptozotocin-induced diabetic guinea pigs. J Diabetes Res 2013:860190
Doğan S, Aslan I, Eryılmaz R, Ensari CO, Bilecik T, Aslan M (2013) Early postoperative changes of HDL subfraction profile and HDL-associated enzymes after laparoscopic sleeve gastrectomy. Obes Surg, Jun 14 [Epub ahead of print]
Lagos KG, Filippatos TD, Tsimihodimos V, Gazi IF, Rizos C, Tselepis AD, Mikhailidis DP, Elisaf MS (2009) Alterations in the high density lipoprotein phenotype and HDL-associated enzymes in subjects with metabolic syndrome. Lipids 44(1):9–16
Westerman MP (1975) Hypocholesterolaemia and anaemia. Br J Haematol 31(1):87–94
Zorca S, Freeman L, Hildesheim M, Allen D, Remaley AT, Taylor JG 6th, Kato GJ (2010) Lipid levels in sickle-cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertension. Br J Haematol 149(3):436–445
Marzouki ZM, Khoja SM (2003) Plasma and red blood cells membrane lipid concentration of sickle cell disease patients. Saudi Med J 24(4):376–379
Akinyanju PA, Akinyanju CO (1976) Plasma and red cell lipids in sickle cell disease. Ann Clin Lab Sci 6(6):521–524
Lulla RR, Thompson AA, Liem RI (2010) Elevated soluble transferrin receptor levels reflect increased erythropoietic drive rather than iron deficiency in pediatric sickle cell disease. Pediatr Blood Cancer 55(1):141–144
Ngogang J, Mouray H, Lebreton de Vonne T, Raisonnier A (1989) Erythrocyte and plasma cholesterol exchange in sickle cell anemia. Clin Chim Acta 179(3):295–304
Erasmus RT, Olukoga AO, Ojuawo O (1990) Plasma lipids and lipoproteins in Nigerian children with sickle cell anemia. Ann Trop Paediatr 10(4):421–423
Buchowski MS, Swift LL, Akohoue SA, Shankar SM, Flakoll PJ, Abumrad N (2007) Defects in postabsorptive plasma homeostasis of fatty acids in sickle cell disease. JPEN J Parenter Enteral Nutr 31(4):263–268
Gardner CD, Fortmann SP, Krauss RM (1996) Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 276(11):875–881
Sasaki J, Waterman MR, Cottam GL (1986) Decreased apolipoprotein A-I and B content in plasma of individuals with sickle cell anemia. Clin Chem 32(1 Pt 1):226–227
Fisher EA (2012) The degradation of apolipoprotein B100: multiple opportunities to regulate VLDL triglyceride production by different proteolytic pathways. Biochim Biophys Acta 1821(5):778–781
Fielding CJ, Shore VG, Fielding PE (1972) A protein cofactor of lecithin:cholesterol acyltransferase. Biochem Biophys Res Commun 46(4):1493–1498
Emokpae MA, Uadia PO, Osadolor HB (2010) Lecithin:cholesterol acyltransferase, lipoprotein lipase and lipoproteins in adult Nigerians with Sickle cell disease. Afr J Biochem Res 4(2):17–20
Homan R, Esmaeil N, Mendelsohn L, Kato GJ (2013) A fluorescence method to detect and quantitate sterol esterification by lecithin:cholesterol acyltransferase. Anal Biochem 441(1):80–86
Savel J, Lafitte M, Pucheu Y, Pradeau V, Tabarin A, Couffinhal T (2012) Very low levels of HDL cholesterol and atherosclerosis, a variable relationship—a review of LCAT deficiency. Vasc Health Risk Manag 8:357–361
Hammad SM, Stefansson S, Twal WO, Drake CJ, Fleming P, Remaley A, Brewer HB Jr, Argraves WS (1999) Cubilin, the endocytic receptor for intrinsic factor-vitamin B(12) complex, mediates high-density lipoprotein holoparticle endocytosis. Proc Natl Acad Sci USA 96(18):10158–10163
Acknowledgments
This work was supported by a grant (No.1204 U 0104) from the Mustafa Kemal University Research Foundation.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Ozturk, O.H., Can, Y., Yonden, Z. et al. Lipoprotein Subfraction Profile and HDL-Associated Enzymes in Sickle Cell Disease Patients. Lipids 48, 1217–1226 (2013). https://doi.org/10.1007/s11745-013-3849-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11745-013-3849-4